We use essential cookies and third-party cookies for content.

Arizona Tribune - Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

Arizona Tribune
×
NYSE - LSE
RBGPF -3.2% 70 $
CMSC -0.48% 20.93 $
BCC 0.88% 76.99 $
GSK 0.81% 50.85 $
BCE 1.91% 23.855 $
RIO 0.05% 102.8 $
AZN 1.75% 164.51 $
RELX 3.86% 36.56 $
NGG 0.06% 78.1 $
RYCEF -0.15% 19.56 $
CMSD -0.14% 20.76 $
JRI 0.94% 12.195 $
VOD 3.02% 16.57 $
BP -0.66% 43.64 $
BTI 0.79% 56.125 $
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results

BOULEVARD 07.03.2025

LOS GATOS, CA / ACCESS Newswire / March 7, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the fourth quarter and full year 2024 ended December 31, 2024 after market close on Thursday, March 20, 2025. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analyst.

Text size:

Date:

Thursday, March 20, 2025

Time:

4:30 p.m. Eastern time

Dial-in:

1-877-407-0792

International Dial-in:

1-201-689-8263

Webcast:

TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through April 3, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13751490.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.

The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.

Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]

SOURCE: Tenon Medical, Inc.



View the original press release on ACCESS Newswire

A.Moore--AT

Featured

37 people die from fumes during oil pipeline theft in Nigeria: NGO

37 people die from fumes during oil pipeline theft in Nigeria: NGO
Nothing left: Nepal flood survivors face loss and uncertainty

Nothing left: Nepal flood survivors face loss and uncertainty
Cafe at centre of Israel culture clash agrees to shut on Sabbath

Cafe at centre of Israel culture clash agrees to shut on Sabbath
Initial expert report blames tanker for collision off Istanbul

Initial expert report blames tanker for collision off Istanbul